Preparation of Peptide-Loaded Dendritic Cells for Cancer Immunotherapy

By Morse Michael A.   Clay Tim   Colling Kirsten   Lyerly H. Kim  

Molecular Biotechnology, Vol. 25, Iss. 1, 2003-09 ,pp. : 95-100

Humana Press, Inc

Access to resources Recommend Favorite

The use of BRM-activated killer cells in adoptive immunotherapy: A pilot study with nine advanced cancer patients

By Ebina T.  

Biotherapy, Vol. 11, Iss. 4, 1998-01 ,pp. : 241-253

Springer Publishing Company

Access to resources Recommend Favorite

A Novel Method for Modification of Tumor Cells with Bacterial Superantigen with a Heterobifunctional Cross-Linking Agent in Immunotherapy of Cancer

By Shimizu Motomu   Matsuzawa Akio   Takeda Yasutaka  

Molecular Biotechnology, Vol. 25, Iss. 1, 2003-09 ,pp. : 89-94

Humana Press, Inc

Access to resources Recommend Favorite

Modification of Tumor Cells with Fas (CD95) Antigen Gene and Fas Ligand (CD95L) Gene Transfection by Electroporation for Immunotherapy of Cancer

By Shimizu Motomu   Yoshimoto Takayuki   Matsuzawa Akio   Takeda Yasutaka  

Molecular Biotechnology, Vol. 25, Iss. 1, 2003-09 ,pp. : 79-88

Humana Press, Inc

Access to resources Recommend Favorite

Augumentation of splenic antitumor immunity by local immunotherapy in gastric cancer patients

By Wakasugi T.   Takeda T.   Monden T.   Katsumoto Y.   Sakita I.   Nagaoka H.   Fukunaga M.   Tomita N.   Kobayashi T.   Shiozaki H.   Shimano T.   Monden M.  

Biotherapy, Vol. 10, Iss. 2, 1997-01 ,pp. : 99-106

Springer Publishing Company

Access to resources Recommend Favorite